Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex)

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3607-3614

  Stratakis, Constantine A ^a,e   Jenkins, Robert B ^c   Pras, Elon ^b   Mitsiadis, Constantine S ^a   Raff, Sandra B ^d   Stalboerger, Paul G ^c   Tsigos, Constantine ^a   Carney, J Aidan ^c   Chrousos, George P ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c MAYO CLINIC   (United States)

^d NEW BRITAIN GENERAL HOSPITAL   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME ANALYSIS; CHROMOSOME MAP; CHROMOSOME SATELLITE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOSIS; MULTIPLE ENDOCRINE NEOPLASIA; MYXOMA; PRIORITY JOURNAL; SKIN PIGMENTATION; TELOMERE;

ACROMEGALY; ADENOMA; ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 2; CUSHING SYNDROME; DNA, NEOPLASM; ENDOCRINE GLAND NEOPLASMS; FEMALE; HUMANS; KARYOTYPING; LENTIGO; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MYXOMA; NEOPLASTIC SYNDROMES, HEREDITARY; THYROID NEOPLASMS;

NOTOLABRUS CELIDOTUS;

EID: 0029838757     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3607     Document Type: Article

References (54)

1. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VLW. 1985 The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine. 64:270-283.
2. Carney JA, Headington JT, Su WPD. 1986 Cutaneous myxomas. A major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol. 122:790-798.
3. McCarthy PM, Piehler JM, Schaff HV, et al. 1986 The significance of multiple, recurrent, and "complex" cardiac myxomas. J Thorac Cardiovasc Surg. 91:389-396.
4. Carney JA. 1985 Differences between nonfamilial and familial cardiac myxoma. Am J Surg Pathol. 9:53-55.
5. Van Gelder HM, O'Brien DJ, Staples ED, Alexander JA. 1992 Familial cardiac myxoma. Ann Thorac Surg. 53:419-424.
6. Carney JA, Toorkey BC. 1991 Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast: a heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol. 15:713-721.
7. Cook CA, Lund BA, Carney JA. 1987 Mucocutaneous pigmented spots and oral myxomas: the oral manifestations of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Oral Surg Oral Med Oral Pathol. 63:175-183.
8. Ferreiro JA, Carney JA. 1994 1994 Myxomas of the external ear and their significance. Am J Surg Pathol. 18:274-280.
9. Burgdorf WHC, Koester G. 1992 Multiple cutaneous tumors: what do they mean? J Cutan Pathol. 19:449-457.
10. Grossniklaus HE, McLean JW, Gillespie JJ. 1991 Bilateral eyelid myxomas in Carney's complex. Br J Ophthalmol. 75:251-252.
11. Utiger CA, Headington JT. 1993 Psammomatous melanotic schwannoma: a new cutaneous marker for Carney's complex. Arch Dermatol. 129:202-204.
12. Carney JA. 1990 Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol. 14:206-222.
13. Yen RS, Allen BR, Ott R, Brodsky M. 1992 The syndrome of right atrial myxoma, spotty skin pigmentation, and acromegaly. Am Heart J. 123:243-244.
14. Manthos CL, Sutherland RS, Sims JE, Perloff JJ. 1993 Carney's complex with hormone-producing Sertloli cell tumor of the testicle. J Urol. 150:1511-1512.
15. Carney JA, Toorkey BC. 1991 Ductal adenoma of the breast with tubular futures. A probable component of the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Am J Surg Pathol. 15:722-731.
16. Stratakis CA, Carney JA, Lin J-P, et al. 1996 Carney complex: a familial multiple neoplasia and lentiginosis syndrome: analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 97:599-607.
17. Dewald GW, Dahl RJ, Spurbeck JL, Carney JA, Gordon H. 1987 Chromosomally abnormal clones and nonrandom telomeric translocations in cardiac myxomas. Mayo Clin Proc. 62:558-567.
18. Dijkhuizen T, van der Derg E, Molenaar WM, Meuzelaar JJ, de Jong B. 1992 Cytogenetics of a case of cardiac myxoma. Cancer Genet Cytogenet. 63:73-75.
19. Leach FS, Nicolaides NC, Papadopoulos N, et al. 1993 Mutations of a muts homolog in hereditary nonpolyposis colorecteal cancer. Cell 75:1215-1225.
20. Palombo F, Gallinari P, laccarino, et al. 1995 GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science. 268:1912-1914.
21. Fishel R, Ewel A, Lee S, Lescoe MK, Griffith J. 1994 Binding of mismatched microsatellite DNA sequences by the human MSH2 protein. Science. 266:1403-1405.
22. Richkind KE, Wason D, Vidaillet HJ. 1994 Cardiac myxoma characterized by clonal telomeric association. Genes Chrom Cancer. 9:68-71.
23. Genethon. 1994. The 1993-1994 Genethon human genetic linkage map. Nature Genet. 7:221-1246.
24. Reynen K. 1995 Cardiac myxomas. N Engl J Med. 24:1610-1617.
25. Vogelstein B, Kinzler KW. 1993 The multistep nature of cancer Trends Genet. 4:138-141.
26. Gruis NA, Abelin EC, Bardoel AFJ, Devillee P, Frants RR, Cornelisse CJ. 1993 PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumor tissue. Br J Cancer. 68:308-313.
27. Shibata D, Peinado M-A, Ionov Y, et al. 1994 Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nature Genet. 6:273-280.
28. Kraehn GM, Schartl M, Peter RU. 1995 Human malignant melanoma. A genetic disease? Cancer. 75:1228-1237.
29. Radford DM, Fair KL, Phillips P. 1995 Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17q, and 17q. Cancer Res. 55:3399-3405.
30. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ, Goodfellow PJ. 1995 Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res. 55:1922-1926.
31. El-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V. 1995 Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res. 55:2656-2659.
32. Nakashima H, Inoue H, Honda M, et al. 1995 The hetrogeneity of microsatellite instability in multiple gastric cancers. Am J Gastroenterol. 90:653-656.
33. Peng H-Q, Bailley D, Bronson D, Goss PE, Hogg D. 1995 Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res. 55:2871-2875.
34. Cryns VL, Yi SM, Tahara H, Gaz RD, Arnold A. 1995 Frequent loss of chromosome arm Ip DNA in parathyroid adenomas. Genes Chromosomes Cancer. 13:9-17.
35. Herman V, Drazin NZ, Gonsky R, Melmed S. 1993 Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab. 77:50-55.
36. Arnold A. 1994 Molecular mechanisms of parathyroid neoplasia. Endocrinol Metab Clin North Am. 23:93-116.
37. Vermiglio F, Schlumberger M, Lazar V, Lefrere I, Bressac B. 1995 Absence of microsatellite instability in thyroid carcinomas. Eur J Cancer. 31A:128-129.
38. Coleman A, Robertson G, Lugo TG. 1995 Growth control by tumor suppressors in malignant melanoma. Receptor. 5:9-19.
39. Wiltshire RN, Duray P, Bittner ML, Visakopri T, Trent JM. 1995 Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization. Cancer Res. 55:3954-3957.
40. Parmitter AH, Nowell PC. 1993 Cytogenetics of melanocytic tumors. J Invest Dermatol. 100:254S-258S.
41. Jadayel D, Calabrese G, Min T, van Rhee F. 1995 Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9)(p23↘4) traslocation. Leukemia. 9:981-987.
42. Aguado B, Campbell RD. 1995 The novel gene G17, located in the human histocombatibility complex, encodes PBX2, a homeodomain containing protein. Genomics. 25:650-659.
43. Knudson Jr AG. 1993 Introduction to the genetics of primary renal tumors in children. Med Pediatr Oncol. 21:193-198.
44. Liu J, Kahri AI, Heikilla P, Ilvemaki V, Voutillainen R. 1995 H-19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab. 80:492-496.
45. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. 1993 An association between the risk of cancer and mutations in the HRASI minisatellite locus. N Engl J Med. 329:517-523.
46. MacCollin M. 1995 Molecular analysis of the neurofibromatosis 2 tumor suppressor gene. Brain Dev. 17:231-238.
47. Calender A, Schuffenecker I, Lenoir GM. 1992 The genetics of multiple endocrine neoplasia (MEN). Horm Res. 38(Suppl 2):16-23.
48. Gollin SM, Jenkins RB, Swaney WP, Mulvihil JJ, Bartelt Jr D, Nwokoro NA. 1995 10q26:consistent chromosomal breakpoint in two cardiac myxomas from apatient with Carney syndrome. Am J Hum Genet. 57:A65.
49. Cairns P, Polascik TJ, Eby Y, et al. 1995 Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genet. 11:210-212.
50. Zenkusen JC, Thompson JC, Klein-Szanto AJ, Conti CJ. 1995 Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31: evidence for a broad range tumor suppressor gene. Cancer Res. 55:1347-1350.
51. Toribara NW, Sleisenger MH. 1995 Screening for colorectal cancer. N Engl J Med. 332:861-867.
52. Apte SS, Mattel MG, Olsen BR. 1995 Mapping of the human BAX gene to chromosome 19q13.3-19q13.4. Genomics. 26:592-594.
53. Liu JH, Mu ZM, Chang KS. 1995 PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J Exp Med. 181:1965-1973.
54. Uejima H, Mitsuya K, Hiroyuki K, Horikawa I, Oshimura M. 1995 Normal human chromosome 2 induces cellular senescence in the human cervical carcinoma cell line SiHa. Genes Chromosom Cancer. 14:120-127.